AMAT vs ENTA · P/E 56, rev $24.04B vs rev $65.3M
Applied Materials Inc (AMAT) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the AMAT and ENTA stock pages for the full models.
Not investment advice.